Clinical Trial Update: Vasovist Magnetic Resonance Angiography (MRA) in Peripheral Arterial Occlusive Disease [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Vasovist-enhanced magnetic resonance angiography for Peripheral Arterial Occlusive Disease was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Arterial Occlusive Disease

Drugs mentioned

• Vasovist (gadofosveset trisodium)

Snippet

Sponsor: Heidelberg University | Conditions: Peripheral Arterial Occlusive Disease | Phase 4 | Status: TERMINATED